Medpace Holdings, Inc. — Company profile

Healthcare · Diagnostics & Research · United States

Last price 652.01 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 18.24B

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Company profile

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, Asia, South America, Africa, and Australia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.

Details

Key executives

Contact